July 11, 2023 Comments Off on New patent for Glaxo Grp drug BREO ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatent…
July 11, 2023 Comments Off on New patent for LUPIN drug SOLOSEC Posted in: Patent Added Annual Drug Patent Expirations for SOLOSEC Solosec is a drug marketed by Lupin and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for LUPIN drug SOLOSEC appeared first on DrugPatentWat…